Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Effects of Baedokhwan on Immune Modulation in Atopic Dermatitis Model of NC/Nga Mice

배독환(排毒丸)의 아토피피부염 병태모델에서의 면역 억제 효능

  • Lee, Jong-Hyub (Department of Pathology, College of Oriental Medicine, Daejeon University) ;
  • Gim, Seon-Bin (Department of Pathology, College of Oriental Medicine, Daejeon University) ;
  • Kim, Dong-Hee (Department of Pathology, College of Oriental Medicine, Daejeon University)
  • 이종협 (대전대학교 한의과대학 병리학교실) ;
  • 김선빈 (대전대학교 한의과대학 병리학교실) ;
  • 김동희 (대전대학교 한의과대학 병리학교실)
  • Received : 2010.09.20
  • Accepted : 2010.10.14
  • Published : 2010.10.25
Download PDF
⟨ Previous Next ⟩

Abstract

Atopic dermatitis induced NC/Nga mice were used to investigate the efficacy of BDH(Baedokhwan) on the recovery of dermatitic symptoms through its influence on the immune related factors and histological changes. First of all, BDH treated group showed improvement of atopic dermatitis with naked eye observation, and significant decrease of clinical index(CI) was observed after 14 weeks. And Infiltration of leukocytes was suppressed in BDH treated group, and the thickness of hypertrophied epidermis and dermis were decreased. In dorsal skin, BDH treated group showed significant decrease of the ratio of CD3+, CD11b+/Gr-1+ immune cells by 52.8%, 25.2, respectively. And also significant decrease the level of IL-5 mRNA and IL-13 mRNA by 44.4%, 28.0, respectively. In PBMC and serum, BDH treated group showed an decrease of CD4+/CD45+, B220+/CD23+, CD4+, CD8+, CD4+/CD25+ immune cells by 35.0%, 12.6%, 42.7%, 31.6% and 55.6%, respectively, and the level of histamine was decreased by 39.0%. The results above indicated that BDH clinically used for atopic dermatitis treatment has objective validity, and therefore can be provided as the basic data for anti-allergic and anti-inflammatory studies.

Keywords

References

  1. Leung, D.Y. Atopy dermatitis: new insight and opportunities for therapeutic intervention. J Allergy Clin Immunol., 105: 860-867, 2000. https://doi.org/10.1067/mai.2000.106484
  2. Suto, H., Matsuda, H., et al. Nc/Nga mice : a mouse model for atopic dermatitis. Int Arch Allergy Immunol, 12 suppl., 1999.
  3. Yawalkar, N., Uguccioni, M., Scharer, J., et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol., 113: 43-48, 1999. https://doi.org/10.1046/j.1523-1747.1999.00619.x
  4. 楊志波 외. 皮膚病, 人民軍醫出版社, pp 109-133, 2007.
  5. 박영립 외. 아토피 피부염의 병인, 대한피부연구학회지 14(3):37-72, 2007.
  6. 보건복지부. 2008 주요 업무 참고자료, p 326, 2008.
  7. 이윤미 외. 학령전기와 학령기 아동에서의 아토피 피부염 유병률과 위험인자. 아동간호학회지 14(3):285-294, 2008.
  8. Leung, Y.M.D., Eichenfield, L.F., Boguniewicz, M. Atopy dermatitis, In : Freedberg, I.M., Eisen, A.Z., Wolff, K., Austen, K.F., Goldsmith, L.A., Katz, S.I. editors. Fitzpatrick's dermatology in general medicine. 6th ed, New York: McGraw-Hill, pp 1180-1194, 2003.
  9. Barnetson, R.S.C., & Rogers, M. Childhood atopic eczema. BMJ, 324(7350):1376-1379, 2002.
  10. 김은정 외. 아토피피부염 환자의 삶의 질과 경제적 부담에 관한 연구. 대한피부과학회지 46(2):160-170, 2008.
  11. Cooper, K.D. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol., 102: 128-137, 1994. https://doi.org/10.1111/1523-1747.ep12371746
  12. Beltrani, V.S. The role of house dust mites and other aeroallergens in atopic dermatitis, Clin Dermatol, 21(3):177-182, 2003. https://doi.org/10.1016/S0738-081X(02)00366-8
  13. Rabito, F.A., et al. Prevalence of Indoor Allergen Exposures among New Orleans Children with Asthma, J Urban Health, 84(6):782-792, 2007. https://doi.org/10.1007/s11524-007-9216-0
  14. 謝 娟 외. 皮膚病奇效良方. 인민군의출판사, pp 170-178, 2007.
  15. 林俊華 외. 皮膚性病科絕技, 과학기술문헌출판사, pp 131- 133, 2002.
  16. 馬紹堯. 實用中醫皮膚病學. 상해중의약대학출판사, pp 244- 246, 1999.
  17. 민영규. 消風散加減方과 外治方 병용이 NC/Nga 아토피 생쥐에 미치는 영향, 동신대학교대학원, 2005.
  18. 박민철. 柴胡淸肝散 투여가 아토피 피부염을 유발한 동물모델의 각질층 기능 회복에 미치는 영향. 동국대학교대학원, 2004.
  19. 권오성. 連翹敗毒散加味方이 DNCB로 誘導된 생쥐의 Allergy性 接觸皮膚炎에 미치는 影響. 동국대학교대학원, 1997.
  20. 김정진 외. 加味生科四物湯의 抗炎症 효과와 止痒膏의 아토피피부염 손상 및 止痒 효과에 미치는 영향. 대한동의병리학회지 17(2):428-435, 2003.
  21. 이원구. 消疹止痒湯의 NC/Nga 생쥐에 유발된 아토피 피부염 抑制 效果와 免疫 調節 作用. 대전대학교대학원, 2008.
  22. 이현주 외. 烏藥이 토끼의 수축혈관에 미치는 영향. 한국한의학연구원논문집, 11(1):97-107, 2005.
  23. 김시나 외. 갈근 추출물에 의한 염증성 Cytokine 생성 억제 및 Prostaglandin E2 활성 저해에 관한 연구. 한국식품영양과학회지 35(1):28-34, 2006.
  24. 김태희 외. 마황의 면역작용에 미치는 효과. 생약학회지 22(3):183-191, 1991.
  25. 박히준 외. 계지의 항염 효과에 관한 연구. 대한한의학회지 26(2):140-151, 2005.
  26. 박혜란 외. 당귀 물추출물의 면역증강 효과. J. Life Resources & Industry, 3: 80-88, 1998.
  27. 이양숙 외. 백지의 항산화성 및 생리기능. 학국식품영양과학회지 36(1):20-26, 2007.
  28. 강영성 외. 蘇葉에 의한 알레르기 천식효과에 대한 연구. 대한본초학회지 19(3):25-34, 2004.
  29. 황상준 외. 桃仁 및 紅花를 포함하는 方藥合編處方에 대한 考察. 대전대학교한의학연구소 논문집, 13(1):311-320, 2004.
  30. 金東煥 외. 桃仁 및 紅花 藥鍼의 鎭痛․抗血栓 效能에 關한 硏究. 대한한방부인과학회지 13(2):60-73, 2000.
  31. Turner, M.W. Allergy in infancy and childhood. Part I;Genetic Aspects. MTP Press, p 101, 1981.
  32. Diepgen. T.L., et al. Recent epidemiologic and genetic studies in atopic dermatitis. Acta Derm Venerol, 176: 13-18, 1992.
  33. Moore, M.M., et al. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics, 113: 468-474, 2004. https://doi.org/10.1542/peds.113.3.468
  34. McIntire, V.K., et al. Identufication of Tapr(an airway hyperactivity regulatory locus) and linked TIM gene family. Nat Immunol., 12: 1109-1111, 2001.
  35. 안성구 외. 아토피피부염, 퍼시픽출판사, pp 36-39, 40, 41-44, 48-49, 2007.
  36. 박용민. 아토피피부염 병태생리에 대한 최신 지견. 소아알레르기 호흡기, 16(3):189-196, 2006.
  37. Hill, P.B., et al. The ACVD task force on canine atopic dermatitis (IV): environmental allergens. Vet Immunol Immunopathol, 81(3-4):169-186, 2001. https://doi.org/10.1016/S0165-2427(01)00298-7
  38. Valenta, R., et al. Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol., 105(3):432-437, 2000. https://doi.org/10.1067/mai.2000.104783
  39. Sampson, H.A., et al. Food allergies. JAMA, 268: 2840-2844, 1992. https://doi.org/10.1001/jama.268.20.2840
  40. Ssmpson, H.A., et al. Natural history of food hypersensitivity in children with atpic dermatitis. J Pediatr, 115: 23-27, 1989. https://doi.org/10.1016/S0022-3476(89)80323-3
  41. 이종태 외. 소아 아토피 및 천식관련 입원과 대기 중 오존의 상관성 분석. 한국보건교육․건강증진학회 학술대회 발표논문집, pp 73-77, 2006.
  42. Novak, N., et al. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol, 112: 252-262, 2003. https://doi.org/10.1067/mai.2003.1595
  43. Hoffman, D.R., et al. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol, 55: 256-267, 1975. https://doi.org/10.1016/0091-6749(75)90145-1
  44. Sampson, H.A., et al. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med., 321(4):228-232, 1989. https://doi.org/10.1056/NEJM198907273210405
  45. Kyoko, K., et al. Flow cytometric analysis of IL-4, IL-13 and IFN-$\gamma$ expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J. Dermatol. Sci., 29: 19-25, 2002. https://doi.org/10.1016/S0923-1811(01)00174-8
  46. Inagaki, N., et al. Drugs for the treatment of allergic diseases. Jpn J. Pharmacol. 86: 275-280, 2001. https://doi.org/10.1254/jjp.86.275
  47. Mosmann, T.R., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136: 2348-2357, 1986.
  48. Miraglia del Giudice M., et al. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc., 27(6):451-455, 2006. https://doi.org/10.2500/aap.2006.27.2887
  49. Antunez, C., et al. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma. Pediatr Allergy Immunol., 17(3):166-174, 2006. https://doi.org/10.1111/j.1399-3038.2006.00390.x
  50. Grewe, M., et al. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol., 105: 407-410, 1995. https://doi.org/10.1111/1523-1747.ep12321078
  51. Grewe, M., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today, 19: 359-361, 1998. https://doi.org/10.1016/S0167-5699(98)01285-7
  52. Schreiber, S.L., et al. The mechanism of action of cyclosporin A and FK506. Immunol Today, 13(4):136-142, 1992. https://doi.org/10.1016/0167-5699(92)90111-J
  53. Jang, H.S. Diagnosis and treatment of atopic dermatitis. J Kor. Acad. Fam. Med. 23: 831-840, 2002.
  54. Roess, D.A., et al. The effect of glucocorticoids on mitogenstimulated B-lymphocytes: Thymidine incorporation and antibody secretion. Endocrinology, 110: 169-175, 1982. https://doi.org/10.1210/endo-110-1-169
  55. Sabbele, N.R., et al. The effect of corticosteroids upon murine B cell in vivo and in vitro as determined in the LPS-culture system. Immunology, 62: 285-290, 1987.
  56. Vestergard, C., et al. The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today, 6(5):209-210, 2000. https://doi.org/10.1016/S1357-4310(00)01683-X
  57. Matsuda, H., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 9: 461-466, 1997. https://doi.org/10.1093/intimm/9.3.461
  58. Matsumoto, M., et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol., 162(2):1056-1063, 1999.
  59. Shiohara, T., et al. Animal models for atopic dermatitis: are they relevant to human disease? J. Dermatol. Sci. 36(1):1-9, 2004. https://doi.org/10.1016/j.jdermsci.2004.02.013
  60. Jun-Won Yun, et al. Comparative Evaluation of Animal Models for Atopic Dermatitis in NC/Nga mice, Lab. Anim. Res. 24(1):59-66, 2008.
  61. Harada, D., et al. Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application. J. Dermato. Sci. 37(3):159-167, 2005. https://doi.org/10.1016/j.jdermsci.2004.11.007
  62. Ueda, Y., et al. A new chronic itch model accompanied by skin lesions in hairless mice. Int Immunopharmcol., 6(10):1609-1615, 2006. https://doi.org/10.1016/j.intimp.2006.06.002
  63. Watanabe, A., et al. Transfer of allergic airway responses with antigen-premed CD4+ but not CD8+ T cells in brown Norway rat. J Clin Invest. 96: 1303-1310, 1995. https://doi.org/10.1172/JCI118165
  64. Abul, K. Abbas, et al. 세포분자면역학(Cellular and Molecular Immunology, 6/E), 이퍼블릭, p 51, 55, 148, 150, 431, 533, 2008.
  65. Hoglund, P. Induced peripheral regulatory T cells : the family grows larger. Eur J Immunol., 36: 264-266, 2006.
  66. Laky, K., et al. TCR and Notch signaling in CD4 and CD8 T-cell development. Immunol Rev., 209: 274-283, 2006. https://doi.org/10.1111/j.0105-2896.2006.00358.x
  67. Bromberg, J.S. The biology of CD2: adhesion, transmembrane signal, and regulatory receptor of immunity. J Surg Res., 54: 258-267, 1993. https://doi.org/10.1006/jsre.1993.1041
  68. 허지영. 三子養親湯 물 추출물이 마우스 면역세포 B cell 분화와 Cytokines 분비에 미치는 영향, 경희대학교대학원, 2008.
  69. Getahun, A., et al. IgE enhances antibody and T cell responses in vivo via CD23+ B cells. J Immunol., 175(3):1473-1482, 2005. https://doi.org/10.4049/jimmunol.175.3.1473
  70. Li, Y.S., et al. Identification of the earliest B lineage stage in mouse bone marrow. Immunity, 5(6):527-535, 1996. https://doi.org/10.1016/S1074-7613(00)80268-X
  71. Bieber, T., et al. CD69, an early activation antigen on lymphocytes is constitutively expressed by human epidermal Langerhans cells. J Invest Dermatol., 98(5):771-776, 1992. https://doi.org/10.1111/1523-1747.ep12499948
  72. 김세종. 면역학, 고려의학, p 5, 32, 1994.
  73. Kang, H.K., et al. Regulatory T cells in lupus. Int Rev Immunol., 25(1-2):5-25, 2006. https://doi.org/10.1080/08830180500544480
  74. Kay, A.B., et al. Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5 and granulocyte/macrophage colony stimulating factor, in allergen-induced late phase cutaneous reactions in atopic subjects. J Exp Med, 173: 775-778, 1995.